Cerebrovasculoprotective effects of azilsartan medoxomil in diabetes.

about

Azilsartan as a Potent Antihypertensive Drug with Possible Pleiotropic Cardiometabolic Effects: A Review Study Azilsartan medoxomil in the management of hypertension: an evidence-based review of its place in therapy

P2860

Q26740629-6BD07625-C8D1-4028-BB05-C48419F82B86 Q26751126-B215275F-77B4-47FF-BA2A-A71A72F967E6

P2860

Cerebrovasculoprotective effects of azilsartan medoxomil in diabetes.

Item

http://www.wikidata.org/entity/Q41880978

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Cerebrovasculoprotective effects of azilsartan medoxomil in diabetes.

@en

type

Item

label

Cerebrovasculoprotective effects of azilsartan medoxomil in diabetes.

@en

prefLabel

Cerebrovasculoprotective effects of azilsartan medoxomil in diabetes.

@en

P1476

Cerebrovasculoprotective effects of azilsartan medoxomil in diabetes

@en

P2093

Adviye Ergul

http://www.w3.org/2001/XMLSchema#string

Maha Coucha

http://www.w3.org/2001/XMLSchema#string

P2860

Telmisartan, ramipril, or both in patients at high risk for vascular events.

Comparative effects of the angiotensin II receptor blocker, telmisartan, and the angiotensin-converting enzyme inhibitor, ramipril, on cerebrovascular structure in spontaneously hypertensive rats.

Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial.

Vascular protection in diabetic stroke: role of matrix metalloprotease-dependent vascular remodeling

Myogenic tone and reactivity of cerebral arteries in type II diabetic BBZDR/Wor rat

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.

Telmisartan to prevent recurrent stroke and cardiovascular events.

Use of Angiotensin receptor blockers in cardiovascular protection: current evidence and future directions.

Endothelial endothelin B receptor-mediated prevention of cerebrovascular remodeling is attenuated in diabetes because of up-regulation of smooth muscle endothelin receptors.

Influence of hyperglycemia on oxidative stress and matrix metalloproteinase-9 activation after focal cerebral ischemia/reperfusion in rats: relation to blood-brain barrier dysfunction

P304

424-432

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.TRSL.2014.06.003

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

164

http://www.w3.org/2001/XMLSchema#string

P50

Mohammed Abdelsaid

P577

2014-06-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24999268

http://www.w3.org/2001/XMLSchema#string

P932

4250409

http://www.w3.org/2001/XMLSchema#string

Cerebrovasculoprotective effects of azilsartan medoxomil in diabetes.

about

P2860

P2860

Cerebrovasculoprotective effects of azilsartan medoxomil in diabetes.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932